Nexalin Technology (NXL) Operating Income Growth (1y) (2022 - 2026)
Nexalin Technology (NXL) Operating Income Growth (1y) (2022 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Op. Inc Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 199.07 Bn | 193.46 Bn | 7.27 Bn | -17.50% |
| 2 | Stryker | 127.90 Bn | 124.43 Bn | 4.50 Bn | 49.06% |
| 3 | Medtronic | 118.84 Bn | 109.62 Bn | 6.41 Bn | 30.43% |
| 4 | Boston Scientific | 73.33 Bn | 72.79 Bn | 3.85 Bn | 43.83% |
| 5 | Edwards Lifesciences | 51.93 Bn | 47.68 Bn | 1.35 Bn | 24.81% |
| 6 | Dexcom | 34.46 Bn | 32.51 Bn | 830.00 Mn | 49.72% |
| 7 | GE HealthCare Technologies | 33.91 Bn | 31.81 Bn | 2.18 Bn | 13.00% |
| 8 | Koninklijke Philips | 26.36 Bn | 23.04 Bn | 4.55 Bn | 57.74% |
| 9 | Steris | 23.12 Bn | 22.64 Bn | 684.20 Mn | 16.18% |
| 10 | Nexalin Technology | 6.98 Mn | 5.97 Mn | 8,897.00 | -38.65% |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -38.65% |
| Mar 31, 2026 | -5.40% |
| Dec 31, 2025 | 16.08% |
| Sep 30, 2025 | 6.49% |
| Jun 30, 2025 | -24.97% |
| Mar 31, 2025 | -87.32% |
| Dec 31, 2024 | -77.00% |
| Sep 30, 2024 | -3.85% |
| Jun 30, 2024 | -47.92% |
| Mar 31, 2024 | -37.76% |
| Dec 31, 2023 | -125.74% |
| Sep 30, 2023 | -723.87% |
| Jun 30, 2023 | -97.00% |
| Mar 31, 2023 | -107.78% |
| Dec 31, 2022 | -24.61% |
| Sep 30, 2022 | 83.67% |